Antineoplastic cancer treatment prior authorization prohibition

Introduced

In Committee

Floor

Crossed Over

Passed

Enacted

Overview Bill text 2 Compare versions History 3 Sponsors

Mar 10, 2025 · Senate

Comm report: To pass as amended and re-refer to Health and Human Services

Jan 16, 2025 · Senate

Introduction and first reading

Jan 16, 2025 · Senate

Referred to Commerce and Consumer Protection

PASSAGE PROBABILITY

1% Unlikely

Why this number

Stage base Reported from Committee — base rate 11%, measured from MN's completed sessions
Momentum -1 45/100 from the pace of recorded action
Time since last action -22 583 days quiet

A transparent scoring model over stage, momentum, recency, sponsorship and recorded votes — not a trained predictor. Treat it as a way to rank attention, not as a forecast.